Potential for Sustained Release Reduces dosing frequency while maintaining efficacy
Tracking waist circumference, hip circumference, chest measurements, arm circumference, and thigh measurements reveals changes invisible to the scale
For type 2 diabetes , NICE recommends GLP-1 receptor agonists as second- or third-line therapy when metformin and other oral agents have not achieved adequate glycaemic control, or as an alternative to insulin in certain circumstances
Energy gets better if B12 is supported
Both Mounjaro and Zepbound are available in the same dosage strengths: 2.5 mg 5 mg 7.5 mg 10 mg 12.5 mg 15 mg While everyone starts at 2.5 mg weekly, your provider will adjust your tirzepatide dosage based on how your body responds and how well you tolerate the medication
Your prescriber's dosing instructions reflect decades of diabetes and obesity research showing that GLP-1 and GIP agonists work best on a regular, frequent schedule